BXSL:NYSEBlackstone Secured Lending Fund Analysis
Data as of 2026-03-15 - not real-time
$23.65
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Blackstone Secured Lending Fund (BXSL) trades at $23.65, comfortably below its 20‑day ($24.07), 50‑day ($25.15) and 200‑day ($27.99) simple moving averages, signaling a bearish price backdrop. The RSI of 39 hints at modest oversold pressure, while the MACD line sits slightly above its signal (histogram +0.03), offering a faint bullish impulse. Volume remains stable and the price is perched just above the identified support at $23.30, with resistance near $25.07, framing a potential upside of roughly 13% to the median target of $27. Fundamentally, BXSL appears cheap with a trailing P/E of 9.6 versus the industry average of 16.3 and a price‑to‑book of 0.88, yet the dividend yield is exceptionally high at 13% and the payout ratio exceeds 100%, raising sustainability concerns. The fund carries a lofty debt‑to‑equity ratio of 129, reflecting the leveraged nature of BDCs, and a 30‑day volatility of 24% paired with a beta of 0.77, indicating moderate market sensitivity. Recent earnings news is mixed: a reported EPS miss contrasted with a net investment income of $0.80 per share that beat estimates, leaving short‑term sentiment uncertain. Overall, the stock is undervalued on valuation metrics, but the high leverage and dividend sustainability issues temper enthusiasm.
Given the current market sentiment (Fear & Greed Index at 72.9 – “Greed”), the upside potential, and the “Buy” consensus from analysts, a nuanced stance is warranted. The short‑term outlook suggests caution near support, while medium‑term fundamentals support a buying case, and the long‑term view hinges on the fund’s ability to manage debt and maintain dividend payouts.
Given the current market sentiment (Fear & Greed Index at 72.9 – “Greed”), the upside potential, and the “Buy” consensus from analysts, a nuanced stance is warranted. The short‑term outlook suggests caution near support, while medium‑term fundamentals support a buying case, and the long‑term view hinges on the fund’s ability to manage debt and maintain dividend payouts.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price hovering just above technical support
- Recent earnings miss creating near‑term uncertainty
- High dividend yield but payout ratio above 100%
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Undervalued valuation multiples relative to industry
- Potential 13% upside to analyst median target
- Strong net investment income beating estimates
Long Term
> 3 yearsNeutral
Model confidence: 7/10
Key Factors
- Elevated leverage and debt‑to‑equity ratio
- Regulatory environment for BDCs
- Sustainability of the high dividend yield
Key Metrics & Analysis
Financial Health
Revenue Growth1.50%
Profit Margin39.71%
P/E Ratio9.6
ROE9.15%
ROA5.06%
Debt/Equity129.38
P/B Ratio0.9
Op. Cash Flow$-458656992
Free Cash Flow$471.1M
Industry P/E16.4
Technical Analysis
TrendBearish
RSI39.0
Support$23.30
Resistance$25.07
MA 20$24.07
MA 50$25.15
MA 200$27.99
MACDBullish
VolumeStable
Fear & Greed Index72.88
Valuation
Target Price$26.83
Upside/Downside13.42%
GradeUndervalued
TypeValue
Dividend Yield13.02%
Risk Assessment
Beta0.77
Volatility24.09%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.